Spdr Emerging (EMRD) Quote

P' = $10,000 Series OO
U's = 130 bil ÷ 1.2 bil = 108 per share in Series A
Sure wish they would tell us so we would not have to guess hmmmmmmmmmmm

WOW//////////////LOOKS LIKE A 1 for 1 COOP SHARES ??? $108.00 ???

https://x.com/kaboomracks/status/1885239669572477367 still waiting for them to address shareholder concerns.....

Can anyone please tell me what date we can expect a decision from the UK? I have to get a grip on what I need to sell for my upcoming RMDs due by 4/1 and then again by 12/31 (the latest possible dates I have stretched it to).

Hope it is okay to share this cancer story with a happy e

about the same....174 out of 199

You both are paid pumpers 

you're a pos!

silver is the most undervalued commodity since 1980, maybe one of the most undervalued investments since 1999. over 300 paper contracts to an oz, its absolutely insane. when will that bubble burst i do not know

@MrSteven Since I’ve been getting multiple inquiries about the 30th and your a active Indian staff member, I think it’s best if you could confirm or deny whether the staff meeting has taken place.

" I (think) this is it >>

For a fuller picture, watch it on Youtube >

https://www.bing.com/videos/riverview/relatedvideo?q=Tulsi+Gabbard+hearings+on+cspan&mid=3FF8ECBD3169D0AF8C4E3FF8ECBD3169D0AF8C4E&FORM=VIRE

Ask your colleagues. It was Indian staff meeting only. So why ask me?

What is the next date for potential closure of the receivership? Are there any potential dates we should be looking for next? Why cant this receivership close already?!?

Going onto 17 years! What is the longest FDIC has taken to close out a receivership? Are we the longest now?

Time to be careful flipping. This could take off at anytime.

@d_stock07734

·Merck ran a mRNA trial on three tough targets: non-small-cell lung cancer, pancreatic cancer, and colorectal cancer. The trial results were posted two days ago.
https://clinicaltrials.gov/study/NCT03948763
2h

Seventy patients were enrolled.

I prefer two spaces after a period… not bc I’m a boomer (although I am), but because I think it makes the text easier and more inviting to read. One space runs the individual sentences too close together, IMO. :)

United States LNG Export Terminals Approved, Not Yet Built

There is only line item (MC1) under MARAD/USCG.

https://www.ferc.gov/media/us-lng-export-terminals-existing-approved-not-yet-built-and-proposed

As of January 28, 2025
Updated to reflect cha

No, you go figure what the truth is. Just ask ChatGPT or MSFT Copilot, or some other Ai program to get some real answers to your misled beliefs. Dude you are waaay off base with your ideas.

I used to think it wasn't bad that I had around a .06-.07 average. Now I feel it's gonna take a huge pump to get to .01 

Yet another one 

https://x.com/acnewsitics/status/1884957033197097340?s=19

What makes it even more incredible enticing is if we get even 1 fda approval we will go straight towards 50 cents and above if the cards are played correctly Rspi can become a impactful participant if not a mougel in the pharmaceutical sector considering how we have multiple compounds that have been

Amprius SiCore: The Battery That Will Revolutionize EVs and Drones
[yt]yM4QkRee3cY[/yt]

https://news.bloomberglaw.com/tech-and-telecom-law/us-armys-development-of-microsoft-goggles-wins-nominees-praise

President Donald Trump’s nominee for Army secretary praised the service for a strategy that may lead to the purchase of thousands of high-tech goggles developed by Microso

You wouldnt be underwater if you did.
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 20.295px" Nobody reads your BS  style="font-size: 1em"You apparently have no idea how to discern truth from fiction, which is why

Shareholders have never been taken care with zippo substantive accomplishments in 6+ years. Also, potential investors couldn't care less about pushers saying, numerous times, they believe when pushers refuse to buy this near triple zero stock.

MCIC - To Uranus

MAZE IPOs 10.1* shares @$16.00:

https://www.globenewswire.com/news-release/2025/01/31/3018524/0/en/Maze-Therapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering.html Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to dev